A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines

Neurochemical Research

Volumn 21, Issue 10, 1996, Pages 1181-1186

  Summers, Kathleen L ^a   Lippiello, Patrick ^b   Giacobini, Ezio ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

cortex; microdialysis; neurotransmitters; nicotine; RJR 2403

Indexed keywords

ACETYLCHOLINE; DOPAMINE; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINIC AGENT; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE;

ACETYLCHOLINE; ANIMALS; BIOGENIC AMINES; CEREBRAL CORTEX; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICRODIALYSIS; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

ANIMALIA;

EID: 0029909175     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02532393     Document Type: Article

References (11)

1. Summers, K. L., Cuadra, G., Naritoku, D., and Giacobini, E. 1994. Effects of nicotine on levels of acetylcholine and biogenic amines in rat cortex. Drug Dev. Res. 31:108-119.
2. Summers, K. L., and Giacobini, E. 1995. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in rat cortex. Neurochem. Res. 20(6):753-759.
3. Balfour, D. J. K. 1982. The effects of nicotine on brain neurotransmitter systems. Pharmacol. Ther. 16:269-282.
4. Rowell, P. P. 1987. Current concepts on the effects of nicotine on neurotransmitter release in the central nervous system. Adv. Behav. Bio. 31:191-208.
5. McDonald, W. M., and Nemeroff, C. B. 1991. Neurotransmitters and neuropeptides in Alzheimer's disease. Psych. Clinics of North Amer. 14:421-442.
6. Newhouse, P. A., Sunderland, T., Thompson, K., Tariot, P. N., Weingartner, H., Mueller, E. R., Cohen, R. M., and Murphy, D. L. 1986. Intravenous nicotine in a patient with Alzheimer's Disease. Amer. J. Psychiat. 143:1494-1495.
7. Newhouse, P. A., Sunderland, T., Narang, P., Mellow, A. M., Fertig, J. B., Lawlor, B. A., and Murphy D. L. 1990. Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in non-smoking healthy volunteers and patients with Alzheimer's disease. Psychoneuroendocrinology 15:471-484.
8. Jones, G. M. M., and Sahakian B. J. 1989. The effects of nicotine in patients with dementia of the Alzheimer type. Pages 89-96, in Kewitz, T., Thomsen, T., and Bickel, E. (eds), Pharmacological Interventions of Central Cholinergic Mechanisms in Senile Dementia, Zuckschwerdt Verlag, San Francisco.
9. Jones, G. M. M., Sahakian, B. J., Levy, R., Warburton, D. M., and Gray, J. A. 1992. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494.
10. Akaike, A., Tamura, U., Yokota, T., Shimohama, S., and Kimura, J. 1994. Nicotine induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644:181-187.
11. Owman, C., Fuxe, K., Jason, A. M., and Kahrstrom, J. 1989. Studies of protective actions of nicotine on neuronal and vascular functions in the brain of rats: Comparison between sympathetic noradrenergic and mesostriatal dopaminergic fiber systems, and the effect of a dopamine agonist. Prog. Brain Res. 79:267-276.